R227.42
+ R1.17 (0.51%)
End-of-day quote: 05/06/2024
JSE:APN

Aspen Pharmacare Holdings Profile

Aspen Pharmacare Holdings Limited, through its subsidiaries, engages in the manufacture, marketing, and distribution of pharmaceutical, branded consumer, personal care, and infant milk formulation products in the Republic of South Africa.

The company operates primarily in the healthcare industry. It produces generic medicines in South Africa and manufactures and supplies generic antiretroviral to the developing world. The company’s operations also include the manufacture and supply of off-patent active pharmaceutical ingredients.

The company has businesses in South Africa, Australia, India, Cyprus, Brazil, Mexico, Venezuela, Kenya, Tanzania, Uganda, Mauritius, Dubai, and the United Kingdom.

Segments

The South African pharmaceutical division comprises prescription generic and ethical pharmaceutical products, OTC products, and active pharmaceutical ingredients. All products of Schedule 2 and above are included in the pharmaceutical division.

The South African consumer division comprises infant milk formulations, self medication, and personal care products. Schedule 0 and 1 medicines are included in the consumer division.

Strategic Alliances

The company has entered into strategic, inter-dependent transactions with GlaxoSmithKline Group Ltd.

Country
Industry:
Pharmaceutical preparations
Founded:
1850
IPO Date:
02/23/1995
ISIN Number:
I_ZAE000066692

Contact Details

Address:
Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive, La Lucia Ridge, Durban, KwaZulu-Natal South Africa
Phone Number
27 31 580 8600

Key Executives

CEO:
Saad, Stephen
CFO
Capazorio, Sean
COO:
Hill, Lorraine